UPDATE : Thursday, August 6, 2020
Samsung BioLogics to make Ichnos Sciences’ atopic dermatitis treatment
Samsung Biologics said that it has signed a contract with Ichnos Sciences t...
by Lee Han-soo  |  2019-11-05 12:47
Prosecutors seek to arrest 2 Kolon execs for false Invossa data
Prosecutors have sought arrest warrant for two executives of Kolon Life Sci...
by Jeong Sae-im  |  2019-10-31 15:34
Syntekabio passes prior review for Kosdaq listing
Syntekabio, a new drug developer using artificial intelligence (AI)-based g...
by Jeong Sae-im  |  2019-10-31 13:27
Prosecution seeks jail term for Samsung execs for destroying evidence
Prosecutors demanded jail terms of one to four years for Samsung executives...
by Jeong Sae-im  |  2019-10-29 13:10
KangStem Biotech changes strategy for atopic dermatitis drug
KangStem Biotech changed its strategy for Furestem-AD, an investigational s...
by Jeong Sae-im  |  2019-10-28 15:34
Bridge Biotherapeutics passes preliminary review for Kosdaq listing
Bridge Biotherapeutics has passed the regulatory agency’s preliminary revie...
by Jeong Sae-im  |  2019-10-25 15:05
Celltrion launches Herzuma in Brazil
Celltrion Healthcare said that it has launched its anticancer antibody bios...
by Lee Han-soo  |  2019-10-25 13:56
KangStem Biotech fails in phase-3 study on atopic dermatitis drug
KangStem Biotech said it has failed to prove the efficacy of Furestem-AD, a...
by Jeong Sae-im  |  2019-10-25 11:17
Samsung Bioepis' biosimilar sales in EU top $180 million in Q3
Samsung Bioepis' biosimilar sales in European Union surpassed $180 mill...
by Lee Han-soo  |  2019-10-23 17:43
Medipost wins patent for mesenchymal stem cell culture in China
Medipost said that it has registered a patent for cultivating mesenchymal s...
by Lee Han-soo  |  2019-10-23 16:30
Celltrion unveils clinical results of Remsima SC in treating IBD
Celltrion said that is has presented the phase 1, part 2 trial results for ...
by Lee Han-soo  |  2019-10-22 17:00
Biogen, Samsung Bioepis to present biosimilar data at EU conference
Biogen and Samsung Bioepis said that they plan to present new real-world da...
by Lee Han-soo  |  2019-10-22 11:31
Medytox exported ₩3.3 billion worth of unqualified BTX
The Ministry of Food and Drug Safety ordered Medytox to recall and discard ...
by Jeong Sae-im  |  2019-10-18 16:02
State organs squandered ₩8.2 billion; failed to spot Invossa problem
The government invested 8.21 billion won ($6.9 million) in healthcare-relat...
by Kwak Sung-sun  |  2019-10-16 15:06
[Exclusive] Samsung admits it failed to develop Rituxan biosimilar
The Samsung Group has admitted that a Samsung-affiliated company failed to ...
by Jeong Sae-im  |  2019-10-16 14:16
Kolon Life Science shares surge after TissueGene’s survival
Shares of Kolon Life Science shot up after the regulator decided to delay t...
by Jeong Sae-im  |  2019-10-14 18:01
HLB merges with Elevar to own rivoceranib rights
HLB said it would merge with its subsidiary Elevar, a U.S.-based developer ...
by Jeong Sae-im  |  2019-10-14 14:43
Samsung Bioepis to present data of Etanercept biosimilar in Europe
Samsung Bioepis said that it has unveiled the real-world data (RWD) of Bene...
by Lee Han-soo  |  2019-10-10 11:31
‘Kosdaq firms listed for exceptional tech need special monitoring’
About 80 percent of companies listed on the Kosdaq stock market using the r...
by Jeong Sae-im  |  2019-10-07 15:51
SK Plasma launches human immunoglobulin in Brazil
SK Plasma said that it has won the $20-million bid to supply LIV-Gamma, a h...
by Lee Han-soo  |  2019-10-07 11:23
Back to Top